1. HeizmannB, KastnerP, ChanS (2013) Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals. J Exp Med 210: 2823–2832.
2. JohnLB, WardAC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48: 1272–1278.
3. MalingeS, ThiollierC, ChlonTM, DoreLC, DieboldL, et al. (2013) Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling. Blood 121: 2440–51.
4. NgSY, YoshidaT, ZhangJ, GeorgopoulosK (2009) Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30: 493–507.
5. ZhangJ, JacksonAF, NaitoT, DoseM, SeavittJ, et al. (2012) Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat Immunol 13: 86–94.
6. WangJH, NichogiannopoulouA, WuL, SunL, SharpeAH, et al. (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537–549.
7. BottardiS, RossJ, BourgoinV, Fotouhi-ArdakaniN, Affar elB, et al. (2009) Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol Cell Biol 29: 1526–1537.
8. ChoSJ, HuhJE, SongJ, RheeDK, PyoS (2008) Ikaros negatively regulates inducible nitric oxide synthase expression in macrophages: involvement of Ikaros phosphorylation by casein kinase 2. Cell Mol Life Sci 65: 3290–3303.
9. DijonM, BardinF, MuratiA, BatozM, ChabannonC, et al. (2008) The role of Ikaros in human erythroid differentiation. Blood 111: 1138–1146.
10. DumortierA, KirstetterP, KastnerP, ChanS (2003) Ikaros regulates neutrophil differentiation. Blood 101: 2219–2226.
11. PapathanasiouP, AttemaJL, KarsunkyH, HosenN, SontaniY, et al. (2009) Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells 27: 3082–3092.
12. RossJ, MavoungouL, BresnickEH, MilotE (2012) GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis. Mol Cell Biol 32: 3624–3638.
13. YoshidaT, NgSY, GeorgopoulosK (2010) Awakening lineage potential by Ikaros-mediated transcriptional priming. Curr Opin Immunol 22: 154–160.
14. GeorgopoulosK (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2: 162–174.
15. Ferreiros-VidalI, CarrollT, TaylorB, TerryA, LiangZ, et al. (2013) Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood 121: 1769–1782.
16. SchwickertTA, TagohH, GultekinS, DakicA, AxelssonE, et al. (2014) Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol 15: 283–293.
17. KimJ, SifS, JonesB, JacksonA, KoipallyJ, et al. (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345–355.
18. O'NeillDW, SchoetzSS, LopezRA, CastleM, RabinowitzL, et al. (2000) An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol 20: 7572–7582.
19. MiccioA, WangY, HongW, GregoryGD, WangH, et al. (2010) NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J 29: 442–456.
20. ReynoldsN, LatosP, Hynes-AllenA, LoosR, LeafordD, et al. (2012) NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 10: 583–594.
21. WhyteWA, BilodeauS, OrlandoDA, HokeHA, FramptonGM, et al. (2012) Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482: 221–225.
22. YildirimO, LiR, HungJH, ChenPB, DongX, et al. (2011) Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147: 1498–1510.
23. BottardiS, ZmiriFA, BourgoinV, RossJ, MavoungouL, et al. (2011) Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation. Nucleic Acids Res 39: 3505–3519.
24. HarkerN, NaitoT, CortesM, HostertA, HirschbergS, et al. (2002) The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell 10: 1403–1415.
25. KoipallyJ, HellerEJ, SeavittJR, GeorgopoulosK (2002) Unconventional potentiation of gene expression by Ikaros. J Biol Chem 277: 13007–13015.
26. QuirionMR, GregoryGD, UmetsuSE, WinandyS, BrownMA (2009) Cutting edge: Ikaros is a regulator of Th2 cell differentiation. J Immunol 182: 741–745.
27. BottardiS, MavoungouL, BourgoinV, MashtalirN, Affar elB, et al. (2013) Direct Protein Interactions Are Responsible for Ikaros-GATA and Ikaros-Cdk9 Cooperativeness in Hematopoietic Cells. Mol Cell Biol 33: 3064–3076.
28. ZhouQ, LiT, PriceDH (2012) RNA polymerase II elongation control. Annu Rev Biochem 81: 119–143.
29. ChenR, LiuM, LiH, XueY, RameyWN, et al. (2008) PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling. Genes Dev 22: 1356–1368.
30. NekhaiS, PetukhovM, BreuerD (2014) Regulation of CDK9 activity by phosphorylation and dephosphorylation. Biomed Res Int 2014: 964964.
31. D'OrsoI, FrankelAD (2010) HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear. Viruses 2: 2226–2234.
32. JangMK, MochizukiK, ZhouM, JeongHS, BradyJN, et al. (2005) The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19: 523–534.
33. YangZ, YikJH, ChenR, HeN, JangMK, et al. (2005) Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19: 535–545.
34. CeulemansH, BollenM (2004) Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 84: 1–39.
35. PopescuM, GurelZ, RonniT, SongC, HungKY, et al. (2009) Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem 284: 13869–13880.
36. SridharanR, SmaleST (2007) Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. J Biol Chem 282: 30227–30238.
37. RomanoG (2013) Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development. ISRN Oncol 2013: 305371.
38. LuoZ, LinC, ShilatifardA (2012) The super elongation complex (SEC) family in transcriptional control. Nat Rev Mol Cell Biol 13: 543–547.
39. LinC, SmithER, TakahashiH, LaiKC, Martin-BrownS, et al. (2010) AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37: 429–437.
40. WuSY, LeeAY, LaiHT, ZhangH, ChiangCM (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49: 843–857.
41. WinandyS, WuP, GeorgopoulosK (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289–299.
42. NichogiannopoulouA, TrevisanM, NebenS, FriedrichC, GeorgopoulosK (1999) Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 190: 1201–1214.
43. WeissMJ, YuC, OrkinSH (1997) Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 17: 1642–1651.
44. JingH, VakocCR, YingL, MandatS, WangH, et al. (2008) Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell 29: 232–242.
45. NovershternN, SubramanianA, LawtonLN, MakRH, HainingWN, et al. (2011) Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144: 296–309.
46. RahlPB, LinCY, SeilaAC, FlynnRA, McCuineS, et al. (2010) c-Myc regulates transcriptional pause release. Cell 141: 432–445.
47. ReppasNB, WadeJT, ChurchGM, StruhlK (2006) The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting. Mol Cell 24: 747–757.
48. DengC, LiY, LiangS, CuiK, SalzT, et al. (2013) USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription. PLoS Genet 9: e1003524.
49. ChaoSH, FujinagaK, MarionJE, TaubeR, SausvilleEA, et al. (2000) Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 275: 28345–28348.
50. SambolEB, AmbrosiniG, GehaRC, KennealeyPT, DecarolisP, et al. (2006) Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells. Cancer Res 66: 5858–5866.
51. YoshidaT, NgSY, Zuniga-PfluckerJC, GeorgopoulosK (2006) Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 7: 382–391.
52. OrphanidesG, LeRoyG, ChangCH, LuseDS, ReinbergD (1998) FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 92: 105–116.
53. KimT, XuZ, Clauder-MunsterS, SteinmetzLM, BuratowskiS (2012) Set3 HDAC mediates effects of overlapping noncoding transcription on gene induction kinetics. Cell 150: 1158–1169.
54. LiB, GogolM, CareyM, LeeD, SeidelC, et al. (2007) Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science 316: 1050–1054.
55. HuG, WadePA (2012) NuRD and pluripotency: a complex balancing act. Cell Stem Cell 10: 497–503.
56. MullighanCG, GoorhaS, RadtkeI, MillerCB, Coustan-SmithE, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758–764.
57. MullighanCG, MillerCB, RadtkeI, PhillipsLA, DaltonJ, et al. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453: 110–114.
58. MullighanCG, SuX, ZhangJ, RadtkeI, PhillipsLA, et al. (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360: 470–480.
59. AnguitaE, HughesJ, HeyworthC, BlobelGA, WoodWG, et al. (2004) Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. Embo J 23: 2841–2852.
60. BottardiS, RossJ, Pierre-CharlesN, BlankV, MilotE (2006) Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors. Embo J 25: 3586–3595.
61. CaloE, WysockaJ (2013) Modification of enhancer chromatin: what, how, and why? Mol Cell 49: 825–837.
62. JimenezG, GriffithsSD, FordAM, GreavesMF, EnverT (1992) Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc Natl Acad Sci U S A 89: 10618–10622.
63. PilonAM, AjaySS, KumarSA, SteinerLA, CherukuriPF, et al. (2011) Genome-wide ChIP-Seq reveals a dramatic shift in the binding of the transcription factor erythroid Kruppel-like factor during erythrocyte differentiation. Blood 118: e139–148.
64. WuW, ChengY, KellerCA, ErnstJ, KumarSA, et al. (2011) Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res 21: 1659–1671.
65. YeM, IwasakiH, LaiosaCV, StadtfeldM, XieH, et al. (2003) Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19: 689–699.
66. LarochelleS, AmatR, Glover-CutterK, SansoM, ZhangC, et al. (2012) Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat Struct Mol Biol 19: 1108–1115.
67. Gomez-del ArcoP, MakiK, GeorgopoulosK (2004) Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol 24: 2797–2807.
68. GurelZ, RonniT, HoS, KucharJ, PayneKJ, et al. (2008) Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem 283: 8291–8300.
69. AmmosovaT, ObukhovY, KotelkinA, BreuerD, BeullensM, et al. (2011) Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175. PLoS One 6: e18985.
70. MisteliT, SpectorDL (1996) Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol Biol Cell 7: 1559–1572.
71. ShiY, ReddyB, ManleyJL (2006) PP1/PP2A phosphatases are required for the second step of Pre-mRNA splicing and target specific snRNP proteins. Mol Cell 23: 819–829.
72. KimuraY, DingB, ImaiN, NolanDJ, ButlerJM, et al. (2011) c-Kit-mediated functional positioning of stem cells to their niches is essential for maintenance and regeneration of adult hematopoiesis. PLoS One 6: e26918.
73. MassonK, RonnstrandL (2009) Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal 21: 1717–1726.
74. PapathanasiouP, PerkinsAC, CobbBS, FerriniR, SridharanR, et al. (2003) Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19: 131–144.
75. ShinJY, HuW, NaramuraM, ParkCY (2014) High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J Exp Med
76. NakataniY, OgryzkoV (2003) Immunoaffinity purification of mammalian protein complexes. Methods Enzymol 370: 430–444.
77. KroonE, KroslJ, ThorsteinsdottirU, BabanS, BuchbergAM, et al. (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17: 3714–3725.
78. HahmK, ErnstP, LoK, KimGS, TurckC, et al. (1994) The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 14: 7111–7123.
79. MolnarA, GeorgopoulosK (1994) The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14: 8292–8303.
80. SunL, LiuA, GeorgopoulosK (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. Embo J 15: 5358–5369.
81. CarottaS, DakicA, D'AmicoA, PangSH, GreigKT, et al. (2010) The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32: 628–641.